2025-04-13 - Analysis Report
## Philip Morris International Inc. (PM) Stock Review

**0. Key Figures & Initial Analysis:**

Philip Morris International Inc. (PM) is a leading international tobacco company.  The following analysis uses provided data to assess its performance relative to the S&P 500 (VOO).

**1. Cumulative Return Comparison:**

* **PM Cumulative Return:** 79.29%
* **VOO Cumulative Return:** 66.36%
* **Return Difference:** 12.93% (PM outperformed VOO by 12.93%)
* **Relative Divergence:** 84.9% (This indicates PM's outperformance is significantly higher than the minimum historical difference and sits in the upper range of historical relative divergence against VOO.)

The provided Alpha and Beta analysis shows varied performance over different periods.  While some periods show significant alpha (outperformance), others show negative alpha and even negative CAGR.  The market capitalization (Cap(B)) shows consistent growth throughout the provided years.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 24.0% | 4.9% | -5.0% | 111.2 | -0.0 |
| 2016-2018  | -19.0% | 59.7% | -36.0% | 74.2 | 0.0 |
| 2017-2019  | 5.0% | 59.7% | -24.0% | 100.1 | 0.1 |
| 2018-2020  | 1.0% | 63.7% | -25.0% | 103.8 | 1.1 |
| 2019-2021  | 34.0% | 63.7% | -20.0% | 125.4 | 1.6 |
| 2020-2022  | 28.0% | 63.7% | 22.0% | 140.8 | 1.7 |
| 2021-2023  | 13.0% | 70.4% | -4.0% | 138.2 | 0.6 |
| 2022-2024  | 4.0% | 70.4% | -12.0% | 185.7 | 0.5 |
| 2023-2025  | 37.0% | 76.5% | 23.0% | 239.5 | 0.4 |


**2. Recent Price Movement:**

* **Closing Price:** $153.89
* **5-Day Moving Average:** $151.46
* **20-Day Moving Average:** $153.75
* **60-Day Moving Average:** $145.83

The price is slightly above the 20-day moving average and significantly above the 60-day moving average, suggesting a recent upward trend.  The relatively small gap between the closing price and the 20-day MA shows the price movement is not extremely volatile.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk category)  This suggests caution due to high market risk.
* **RSI:** 53.28 (Slightly above neutral; neither overbought nor oversold.)
* **PPO:** -0.51 (Negative, indicating bearish momentum.)
* **Relative Strength Change (20-day):** -11.6% (Recent downward pressure)
* **Price Change:** The recent price increase of $1.8 (1.2%) shows a small, positive day to day movement, not indicating a significant jump in price.
* **Expected Return:** -8.0% (The negative expected return suggests potential for underperformance compared to the S&P 500 over the long term (2+ years).  However, the positive return of 12.93% should be considered when interpreting this.)


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2024-10-24 | 1.98 | $9.91B       |
| 2024-07-25 | 1.54 | $9.47B       |
| 2024-04-26 | 1.38 | $8.79B       |
| 2023-10-26 | 1.32 | $9.14B       |
| 2024-10-24 | 1.32 | $9.14B       | *(Duplicate entry - Likely a data entry error)*

Revenue shows generally stable performance but EPS is fluctuating.  The duplicate entry needs clarification.  A further analysis requires corrected data.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $9.71B | 64.73% |
| 2024-09-30 | $9.91B | 66.04% |
| 2024-06-30 | $9.47B | 64.67% |
| 2024-03-31 | $8.79B | 63.66% |
| 2023-12-31 | $9.05B | 61.73% |

Revenue shows relatively stable performance, while the profit margin remains high but shows some fluctuation.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $-11.75B | 4.93% |
| 2024-09-30 | $-9.69B | -31.79% |
| 2024-06-30 | $-9.74B | -24.69% |
| 2024-03-31 | $-10.31B | -20.84% |
| 2023-12-31 | $-11.22B | -19.56% |


Negative equity is concerning and requires further investigation into the company's balance sheet and accounting practices.  The ROE is also highly volatile and mostly negative, indicating issues with profitability relative to equity.


**6. Overall Analysis:**

PM has shown strong cumulative returns outperforming the S&P 500 over the period considered. However, the recent performance indicators (PPO, Relative Strength Change, and expected return) suggest caution. The negative and highly volatile ROE and negative equity raise significant concerns about the financial health of the company.   Further investigation is needed to understand the reasons behind the fluctuating EPS, negative equity, and negative/volatile ROE. The seemingly stable revenue and high profit margins offer a counterpoint, but the overall picture requires a more in-depth analysis including a review of the company's balance sheet and debt levels to accurately assess the risk-reward profile.  The data provided presents a mixed outlook, requiring further scrutiny before making any investment decisions.  The duplicate entry in the earnings data must also be addressed.
